Evidence map›Paper›PMID 31043691›Full record

Trial reportScientific reports2019

Systemic inflammation is associated with malaria and preterm birth in women living with HIV on antiretrovirals and co-trimoxazole.

Chloe R McDonald, Andrea M Weckman, Andrea L Conroy, Peter Olwoch, Paul Natureeba, Moses R Kamya, Diane V Havlir, Grant Dorsey, Kevin C Kain

Open access · goldAbstract readClinical Trial, Phase IIIRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Chloe R McDonaldSAR Laboratories, Sandra Rotman Centre for Global Health, University Health Network-Toronto General Hospital, Toronto, Ontario, Canada.
Andrea M WeckmanDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Andrea L ConroyDepartment of Pediatrics, Indiana University, School of Medicine, Indianapolis, Indiana, USA.ORCID http://orcid.org/0000-0002-5328-6511
Peter OlwochMakerere University-University of California, San Francisco Research Collaboration, Kampala, Uganda.
Paul NatureebaMakerere University-University of California, San Francisco Research Collaboration, Kampala, Uganda.
Moses R KamyaMakerere University-University of California, San Francisco Research Collaboration, Kampala, Uganda.
Diane V HavlirDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Grant DorseyDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Kevin C KainSAR Laboratories, Sandra Rotman Centre for Global Health, University Health Network-Toronto General Hospital, Toronto, Ontario, Canada. kevin.kain@uhn.ca.
University of California, San Francisco · USUniversity Health Network · CAIndiana University – Purdue University Indianapolis · USUniversity of Toronto · CA

Funding

San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
The immunologic consequences of prenatal exposure to malariaP01HD059454 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2008 to 2017
$22.6M
CIHR FDN -148139NIAID NIH HHS UM1 AI069496NICHD NIH HHS P01 HD059454
6 · The paper itself

Abstract

Women living with HIV (WLHIV) have an increased risk of malaria in pregnancy (MiP). It is unclear if MiP in WLHIV causes a systemic inflammatory response and increases the risk of adverse birth outcomes, especially for women receiving antiretroviral therapy (ART) and daily trimethoprim-sulfamethoxazole (TMP/SXT). We analyzed repeated plasma samples in a cohort of malaria-exposed Ugandan WLHIV receiving ART and daily TMP/SXT to examine changes in inflammatory markers across pregnancy and their association with birth outcomes. Concentrations of CHI3L1, CRP, IL-18BP, IL-6, sICAM-1, and sTNFR2 were quantified by ELISA in 1115 plasma samples collected over pregnancy from 326 women. MiP was associated with increased sTNFR2, sICAM-1 and IL-18BP concentrations across pregnancy. Women who delivered preterm had elevated concentrations of sTNFR2 and altered levels of IL-6 during pregnancy. Women with sTNFR2 concentrations in the highest quartile within 6 weeks of delivery had an increased relative risk of preterm birth. Our results indicate that despite daily TMP/SXT, MiP in WLHIV induced a systemic inflammatory response that was associated with an increased risk of preterm birth. These findings highlight the need for additional strategies to protect WLHIV from malaria infection in pregnancy to promote healthy outcomes for mother and child.

Indexed as

Anti-Retroviral AgentsHIVHIV InfectionsInflammationMalariaPremature BirthTrimethoprim, Sulfamethoxazole Drug CombinationAdultCohort StudiesFemaleHumansIncidenceInfant, NewbornPregnancyPrognosisRisk FactorsAnti-Retroviral AgentsTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID31043691
PMCPMC6494863
OpenAlexW2943543403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.